在早期乳腺癌患者的整个治疗过程中对身体组成动态的描述
Lauren E Rentz1,2, McKinzey K Dierkes2, Beth Vettiyil3
1Division of Exercise Physiology, Department of Human Performance, West Virginia University School of Medicine, Morgantown, WV 26506, USA.
medRxiv : the preprint server for health sciences
|August 6, 2025
概括
乳腺癌患者显示肌肉质量下降和脂肪增加,尽管体重稳定. 计算机断层扫描 (CT) 揭示了传统的缓解症措施所忽略的微妙组织变化,改善了癌症患者的护理.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 身体组成分析 身体成分分析
背景情况:
- 非转移性乳腺癌 (BC) 患者经常经历身体成分变化.
- 传统的基于重量的指标可能无法完全捕捉到这些复杂的形态变化.
研究的目的:
- 描述非转移性乳腺癌女性的计算机断层扫描 (CT) 衍生的身体组成和组织形态.
- 为了将这些变化与健康的对照组和易患性肺癌患者进行比较.
主要方法:
- 截面 (n=56) 和纵向 (n=38) CT成像分析.
- 评估骨肌质量和脂肪组织衰减.
- 乳腺癌,肺癌和健康对照组之间的身体组成指标的比较.
主要成果:
- 乳腺癌患者表现出骨肌质量下降和皮下脂肪组织衰减增加,即使体重稳定.
- 形态变化包括瘦肉组织减少,被增加的分区内脂肪组织掩盖.
- 纵向数据揭示了不同的表型:非卡切斯性BC患者的微妙肌肉重塑与卡切斯性肺癌患者的显著肌肉和脂肪消耗相比.
结论:
- 基于CT的身体组成分析揭示了乳腺癌患者显著的组织重塑,仅仅通过体重监测往往无法检测到.
- 传统的缓解症标准可能低估了早期乳腺癌中临床相关形态变化的患病率.
- CT衍生的表型可以增强对癌症患者的理解,并为癌症患者的支持性护理策略提供信息.
相关概念视频
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


